Patent · US Active

Metabolic biomarker set for assessing ovarian cancer

US11506665B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

BIOCRATES LIFE SCIENCES AG · AT

Inventors

Udo Muller · Unterschleißheim, DE
Simon SCHAFFERER · Zirl, AT
Barbara Burwinkel · Heidelberg, DE

Key dates

Filing date	Jan 18, 2018
Grant date	Nov 22, 2022
Priority date	—
Expiry date	Dec 28, 2038

Classification

Technology area (CPC G)Physics
CPC primaryG01N2405/08
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to new biomarkers for assessing ovarian cancer being more sensitive, particularly at early stage of disease. Moreover, the present invention relates to a method for assessing ovarian cancer from a patient to be examined, and to a kit for carrying out the method.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.